A*STAR Outstanding Publications Award 2009, 2010, 2012, 2013 and 2014
A*STAR Patent Power Award 2009 and 2010
Singapore HEALTH Award (Platinum) 2012, (Gold) 2008 and 2010

ISO Certified (ISO 9001:2008)

OHSAS Certified (SS 506 Part 1:2009/ BS OHSAS 18001:2007



IBN Executive Director Professor Jackie Y. Ying Elected Fellow of the American Association for the Advancement of Science

November 25, 2015 – Professor Jackie Y. Ying, Executive Director of the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR has been named a Fellow of the American Association for the Advancement of Science (AAAS). Prof Ying was nominated by her peers for her distinguished contributions to the fields of nanotechnology and bioengineering, particularly for the design and synthesis of nanomaterials and nanodevices for biomedical and catalytic applications.

“I am honored to be elected as a Fellow of the AAAS, which has made major contributions in its mission to advance science and serve society. My lab has focused on establishing nanotechnology as a tool box with unique properties and functionalities to tackle various scientific challenges. We hope that the new biomedical and green chemistry breakthroughs would have a significant impact on society,” said Prof Ying.

Read more.

Republic Polytechnic Partners IBN to Develop Research Skills in Students

From left: Ms Noreena AbuBakar (IBN Director), Prof Jackie Y. Ying (IBN Executive Director), Mr Seto Lok Yin (RP Deputy Principal of Industry Services) and Mr Ashley Chua Chi Hung (RP Director of School of Applied Science) at the MOU signing.

Republic Polytechnic (RP) has signed a Memorandum of Understanding (MOU) with IBN on October 22, 2015 to equip more students with relevant research skills through the Institute’s Youth Research Program.

IBN Director and Chair of the Youth Research Program, Ms Noreena AbuBakar, said, “We are pleased to strengthen our partnership with RP to help students develop skills that will prepare them for the workplace. Students on research attachments at IBN get to work on interesting biomedical projects under the mentorship of our researchers. They can apply what they learn in the classroom, and pick up new research skills and techniques. Such hands-on experience also helps students to decide whether to pursue further studies and careers in biomedical science.”

Director of School of Applied Science at Republic Polytechnic, Mr Ashley Chua Chi Hung, said, “This MOU marks the growing partnership between RP’s School of Applied Science and IBN. This partnership is timely and aligned with the national SkillsFuture initiative. The MOU will allow the School of Applied Science, in its role as the Ministry of Education’s appointed Biomedical Science sector coordinator, to work with IBN in enhancing the quality of internships and develop graduates with deep industry relevant skills.”

Read more.

Singapore Researchers Develop First Animal-Free Screening Platforms To Predict Toxic Kidney Injury

Front row (seated, left to right): IBN researchers Dr Karthikeyan Kandasamy and Ms Jacqueline Chuah. Second row (left to right): Mr Peng Huang and Dr Sijing Xiong from IBN, Dr Ran Su of BII and IBN’s Dr Daniele Zink. Third row (left to right): IBN’s Mr Kim Guan Eng and Dr Yao Li, with BII’s Dr Lit-Hsin Loo.

October 9, 2015 – Researchers from the Institute of Bioengineering and Nanotechnology (IBN) have developed the first animal-free screening platforms capable of predicting the toxic effects of compounds on the human kidney accurately. Their latest technological advancement involves the use of human induced pluripotent stem cells (iPSCs) in their renal screening platform (Kandasamy et al., 2015). To realize this breakthrough, the scientists have developed an effective way of producing human renal cells from iPSCs, and have combined this with machine learning methods that improved the automated and accurate prediction of nephrotoxicity. In addition to predicting toxicity, the novel iPSC-based platform also correctly identifies injury mechanisms, which can help to advance understanding of the tested compounds.

IBN Executive Director Professor Jackie Y. Ying says, “Our new kidney screening platforms will be very useful for many industries that require a reliable tool for evaluating the safety of compounds and ingredients. For example, the chemical and pharmaceutical industries produce a large number of new compounds that need to be screened and tested. Likewise, there is a demand in the food and consumer care industries for efficient lab tools to predict the safety of novel ingredients in their products.”

Read more.


IBN in the News

Recreating Embryonic Development “In A Dish” To Study Drugs That Cause Birth Defects
Asia Today , 11 Oct 2015

Singapore Develops Animal-Free Screening Platform to Predict Nephrotoxicity
BioSpectrum, 09 Oct 2015

Singapore Researchers Develop 1st Animal-Free Screening Platforms to Predict Toxic Kidney Injury
Xinhua, 09 Oct 2015

More News   


6 Dec - 10 Dec
4th Nano Today Conference

Event Calendar   


NEW! Co-Delivery of Drugs and Plasmid DNA for Cancer Therapy
Advanced Drug Delivery Reviews, (2015)
DOI: 10.1016/j.addr.2015.10.014.
(IF: 15.038) article

NEW! Solid Poly-N-Heterocyclic Carbene Catalyzed CO2 Reduction with Hydrosilanes
Journal of Catalysis, (2015)
DOI: 10.1016/j.jcat.2015.09.009.
(IF: 6.921) article

NEW! Base-Free Conversion of 5-hydroxymethylfurfural to 2,5-furandicarboxylic Acid Over a Ru/C Catalyst
Green Chemistry, (2015)
DOI: 10.1039/C5GC01584G.
(IF: 8.020) article



Research Positions

Institute of Bioengineering and Nanotechnology   31 Biopolis Way, The Nanos, #04-01, Singapore 138669   Tel: +65 6824 7000   Fax: +65 6478 9080   Email: enquiry@ibn.a-star.edu.sg   |   View IBN Privacy Statement